Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. PLTR
4. LITE
5. REGN
6. MRVL
7. CHKP
8. ABBV
9. MAR
10. CL

Go back to Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results

Cellectar Biosciences (CLRB) Misses Q1 EPS by 1c

May 11, 2018 8:09 AM EDT

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).

First Quarter 2018 Financial Results

Research and development expense for the first quarter of 2018 was $2.1 million, compared with $1.9 million for the first quarter of 2017. The year over year increase is attributable to higher preclinical and clinical project costs, manufacturing, and general research and development costs.General and... More